NOX
Click for more information
4.17% 6.9¢ noxopharm limited

Ann: Veyonda Survival Advantage in LuPSMA Therapy Confirmed, page-21

  1. pohutukawa
    121 Posts.
    lightbulb Created with Sketch. 52
    clock Created with Sketch.
    13/08/21
    10:18
    Post #: 55258814

    Combined treatment with paxalisib and mirdametinib significantly extends survival of SJ-DIPGX37-bearing mice.

    Mr Newby, why is it that you apply one standard regarding NOX use of mouse trials, but don’t apply the same standard to KZA, with reference to the above MOUSE trial posted to the KZA board in July 2021?
    NOX Price at posting: 60.0¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 11  Upvote
    lightbulb Created with Sketch. 3  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

MAG Magmatic defines 6km copper trend with grades of up to 6.5% at NSW prospect
right-arrow Created with Sketch.
WCN White Cliff wraps up Canadian fieldwork programs – 'visually confirming' a slew of minerals
right-arrow Created with Sketch.
CPV ClearVue shares up 15% as it inks deal to enter Middle East and Indian construction markets
right-arrow Created with Sketch.
STX Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla
right-arrow Created with Sketch.
POL Polymetals finalises acquisition of Endeavor silver-lead-zinc mine in NSW's Cobar Basin
right-arrow Created with Sketch.
MND Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
6.9¢ 		Change
-0.003(4.17%) 		Mkt cap ! $20.16M
Open High Low Value Volume
6.9¢ 6.9¢ 6.9¢ $3.085K 44.70K

Buyers (Bids)

No. Vol. Price($)
1 22852 6.9¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 1310 1
View Market Depth
Last trade - 15.09pm 02/08/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.